Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × amrubicin × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Specimen Handling 356 Magnetic Resonance Spectroscopy 297 pembrolizumab 296 Biopsy 226 Carboplatin 204 Cyclophosphamide 192 Cisplatin 168 Paclitaxel 154 Nivolumab 139 Gemcitabine 129 Radiotherapy 116 venetoclax 115 Bevacizumab 108 Dexamethasone 107 fludarabine 96 Rituximab 89 Fluorouracil 89 Oxaliplatin 87 Pemetrexed 86 Doxorubicin 84 durvalumab 82 Docetaxel 82 Radiation 79 atezolizumab 78 Prednisone 78 Lenalidomide 76 Ipilimumab 66 Capecitabine 66 Leucovorin 65 X-Rays 64

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06203210 2026-03-02

IDeate-Lung02

Daiichi Sankyo

Phase 3 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡